SCHEMBL7122377

SCHEMBL7122377

COC(=O)c1ccc(OC)c2c1c1c(n2Cc2ccc(F)cc2)CCCC1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 9/20 0.51
HTT P42858 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
ATM Q13315 1/20 0.44
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
FABP3 P05413 2/20 0.42
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PLA2G2A P14555 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7066692 0.90 FABP4 (0.60) FABP4HTTSMN1; SMN2LMNAALDH1A1
SCHEMBL7134032 0.85 FABP4 (0.49) FABP4SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL7131026 0.84 SMN1; SMN2 (0.46) FABP4HTTSMN1; SMN2LMNAALDH1A1
SCHEMBL7163821 0.84 SMN1; SMN2 (0.43) FABP4HTTSMN1; SMN2LMNAALDH1A1
SCHEMBL8323387 0.82 FABP4 (0.43) FABP4HTTSMN1; SMN2LMNAALDH1A1
SCHEMBL7130963 0.82 PDE4D (0.48) FABP4
SCHEMBL7176265 0.80 CNR1 (0.43) FABP4ALDH1A1MAPTMEN1KMT2A
SCHEMBL5023352 0.77 MAPT (0.45) HTTSMN1; SMN2LMNAMAPTNPSR1
SCHEMBL5017992 0.76 LMNA (0.44) HTTSMN1; SMN2LMNAALDH1A1ATM
SCHEMBL5546407 0.75 LMNA (0.45) HTTSMN1; SMN2LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 WO disclosed